Oncotype test

Oncotype Test - What is it for?

The Oncotype Dx Test is used to estimate the genomic prostate cancer score. Therefore, it uses several genes that are most expressed in this neoplasm to gauge its biological aggressiveness. The test is done on biopsy.
hereditary prostate cancer

Hereditary prostate cancer

Hereditary prostate cancer is what passes from parents to their children. Thus, they come from the germline, that is, from the chromosomes of the parents.
T1 Stadium Bladder Cancer

T1 Stadium Bladder Cancer: The Challenge

T1 stage bladder cancer has a recurrence, progression, and mortality rate in 10 years of 74,3%, 33,3%, and 12,3%, respectively.

Lower Urinary Tract Symptoms

LUTS are the signs and symptoms that are reported by patients or that the doctor asks to better quantify their urinary habit.
COPD and hypogonadism

COPD and hypogonadism. Is there relationship?

Chronic obstructive pulmonary disease is systemic with multiple extrapulmonary manifestations. The patient may have low testosterone.
intravesical gemcitabine

Intravesical gemcitabine. When to indicate?

Intravesical gemcitabine is instilled into the bladder after endoscopic resection of low grade tumor. The indication decreases tumor recurrence.
Radical Prostatectomy - Preoperative and Postoperative Care

Intermittent hormone therapy

Intermittent hormone therapy is used to control advanced prostate cancer. The patient is left untreated for some time and resumes based on PSA.
hormone therapy treats prostate cancer

Does hormone therapy treat prostate cancer?

Hormone therapy treats high-risk and advanced prostate cancer. It is a strategy used to cause prostate cancer cell death.
hormone therapy for prostate cancer

Hormone therapy for advanced prostate cancer

Hormone therapy for advanced prostate cancer is indicated when the cancer is locally advanced and / or advanced. More than 90% has a positive response.
× How can I help you?